Association of Serum Docosahexaenoic Acid With Cerebral Amyloidosis
Yassine HN, Feng Q, Azizkhanian I, Rawat V, Castor K, Fonteh AN, Harrington MG, Zheng L, Reed BR, DeCarli C, Jagust WJ, Chui HC
JAMA neurology · 69 citas
Etiquetas de revisión
Financiación no declaradaDatos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.
Cómo se estudió
- Diseño
- Estudio transversal (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiación no declarada
Publicación
- Publicado
- 2016-08-17 · JAMA Neurol · vol. 73 · número 10 · pág. 1208
- Editorial
- American Medical Association
- Citado
- 93 citas · más que el 99% de estudios similares · 10.7× el promedio de su campo
- Impacto
- Entre el 10 % más citado de su campo
- Referencias
- 59 trabajos
- Acceso
- Lectura gratuita
- Áreas de investigación
- Fatty Acid Research and Health · Peroxisome Proliferator-Activated Receptors · Cardiovascular, Neuropeptides, and Oxidative Stress Research
- Palabras clave
- Docosahexaenoic acid, Internal medicine, Amyloidosis, Pittsburgh compound B, Medicine, Amyloid (mycology), Endocrinology, Fatty acid, Alzheimer's disease, Physiology, Gastroenterology, Disease, Polyunsaturated fatty acid, Pathology, Biology, Biochemistry
- MeSH
- humans, brain diseases, alzheimer disease, amyloidosis, aniline compounds, thiazoles, docosahexaenoic acids, positron-emission tomography, cross-sectional studies, aged, aged, 80 and over, female, male, amyloid beta-peptides
12 autores
- Hussein N. Yassine🇺🇸 · autor de correspondenciaUniversity of Southern California
- Qingru Feng🇺🇸University of Southern California
- Ida Azizkhanian🇺🇸University of Southern California
- Varun Rawat🇺🇸University of Southern California
- Katherine Castor🇺🇸Huntington Medical Research Institutes
- Alfred Nji Fonteh🇺🇸Huntington Medical Research Institutes
- Michael G. Harrington🇺🇸Huntington Medical Research Institutes
- Ling Zheng🇺🇸University of Southern California
- Bruce Reed🇺🇸University of California, Davis
- Charles S DeCarli🇺🇸University of California, Davis
- William J. Jagust🇺🇸University of California, Berkeley
- Helena C. Chui🇺🇸University of Southern California
Resumen
El texto original del estudio, en el idioma en que se publicó.
Importance
Higher dietary intake of the essential fatty acid docosahexaenoic (DHA) has been associated with better cognitive performance in several epidemiological studies. Animal and in vitro studies also indicate that DHA prevents amyloid deposition in the brain.
Objective
To determine the association between serum DHA levels, cerebral amyloidosis, and the volumes of brain areas affected by Alzheimer disease.
Design, settings, and participants
Cross-sectional analysis of serum DHA levels together with measures of amyloid deposition (Pittsburgh Compound B index), brain volumes, and neuropsychological testing scores from 61 participants in the Aging Brain Study. The study was conducted between June 2008 and May 2013, and the data were analyzed between October 2015 and April 2016. Linear models were adjusted for age, sex, years of education, and apolipoprotein E status.
Main outcomes and measures
Serum DHA levels with cerebral amyloidosis measured using PIB PET.
Results
Samples were available from 61 Aging Brain Study participants (41 women and 20 men) who underwent amyloid PET imaging. The mean (SD) age of the participants was 77 (6) years and ranged from 67 to 88 years. Serum DHA levels (percentage of total fatty acids) were 23% lower in participants with cerebral amyloidosis than those without (0.97 vs 1.25, P = .007) and were inversely correlated with brain amyloid load (r = -0.32, P = .01) independent of age, sex, apolipoprotein E genotype, and years of education. Moreover, greater serum DHA levels were positively associated with brain volume in several subregions affected by AD, in particular the left subiculum (r = 0.38, P = .005) and the left entorhinal volumes (r = 0.51, P = .001). Serum DHA levels were also associated with nonverbal memory scores (r = 0.28, P = .03).
Conclusions and relevance
In this study, serum DHA levels were associated with pathogenesis of cerebral amyloidosis and with preservation of entorhinal and hippocampal volumes. These findings suggest an important role for DHA metabolism in brain amyloid deposition during the preclinical or early symptomatic stages of Alzheimer disease.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.